AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
The Swiss giant Roche was rebuffed on 24 Feb 2009 in its $42 bn (GBP 29 bn) hostile bid to buy the shares it does not already own in the US biotech group Genentech. The Genentech board advised shareholders to reject the $86.50/share bid for 44% of the group, saying that the …